2-(Trimethylsilyloxy)ethyl methacrylate (HEMATMS) (99%) was purchased from Polysciences. N,N'-dicyclohexylcarbodiimide (DCC), 4-dimethylaminopyridine (DMAP), 4,4'-dinonyl-2,2'-bipyridine (dNbpy, 97%), copper(I) bromide, and tannic acid were purchased from Aldrich and used as received. Doxorubicin hydrochloride (98%) was purchased from Fluka. All other chemicals used in this work were purchased from Aldrich and used without further purification.
polydispersities (M w /M n ) were determined using WinGPC 6.0 software from Polymer Standards Services (PSS). Tapping-mode atomic force microscopy (AFM) measurements were conducted in air with a Dimension 3100 system (Digital Instruments, Santa Barbara, CA) operated under ambient conditions. Multi-angle dynamic light scattering (DLS) study was performed by photon correlation spectroscopy using a Brookhaven Instruments, Co. (Holtsville, NY) system consisting of a model BI-200SM goniometer, a model EMI-9865 photomultiplier, a model BI-9000AT digital correlator, and a Coherent Innova 90C Series ion laser (Santa Clara, CA) operated at 514 nm. All measurements were made at 25 °C; polymer micelle solution was filtered using a 0.45 µm Acrodisc syringe filter (PallCo., Ann Arbor, MI) before measurements. All determinations were made in triplicate and averaged.
C. Synthesis of Polymer.
PEO-Br. PEO macroinitiator was prepared as previously reported.
1
PEO-b-PHEMA-TMS. HEMATMS (2.02 g, 10 mmol), PEO-Br (0.25 g, 0.05 mmol), dNbpy (0.041 g, 0.1 mmol) and anisole (2.0 mL) were added to a 10 mL Schlenk flask equipped with a magnetic stir bar. Oxygen was removed by three freeze-pump-thaw cycles, and CuBr (0.0071 g, 0.05 mmol) was added under nitrogen. The polymerization was conducted at 75 °C for 5 h. The reaction was stopped by opening the flask to air when monomer conversion reached 60%. The catalyst was removed by passing the solution through a neutral alumina column. The polymer was precipitated by addition to cold diethyl ether, and dried under high vacuum at room temperature for 12 h. (DP of PHEMATMS = 120, as determined by 1 H NMR). , and dry DMF (10 mL) were added to a 25 mL round bottom flask. The reaction mixture was stirred overnight at room temperature. Residual NPC groups were subsequently removed by treatment with heptylamine (0.3 g). The resulting reaction mixture was precipitated into cold diethyl ether. The separated precipitate was redissolved in THF (5 mL), reprecipitated into cold diethyl ether, and dried under vacuum at 25 °C for 24 h. GPC: M n = 29,000 g/mol; PDI = 1.28.
D. Micelle Preparation.
Block copolymer micelle of PEO-b-PHEMA was prepared according to the method modified from a literature. Briefly, a stock solution of PEO-b-PHEMA conjugated with doxorubicin (PEO-b-PHEMA-Dox) was freshly prepared in N,N'-dimethylformamide (DMF) at a concentration of 10.0 mg/mL. Then, 200 µL of stock solution was placed in a vial with a gentle stirring. To this solution, 9.8 mL of phosphate buffer (10 mM, pH 7.4) was gradually added with vigorous stirring. After stirring for additional 1 h, the resulting suspension was subjected to dialysis against phosphate buffer (10 mM, pH 7.4) for over 24 h (Spectra/Por 4 Regenerated Cellulose Membrane, MWCO = 12-14 K) to remove any residual solvent and unbound drugs. The resulting PEO-b-PHEMA-Dox micelle (Dox-micelle) was filtered prior to LbL film formation.
E. LbL Film Assembly.
All LbL films were assembled with a modified programmable Carl Zeiss HMS slide stainer. Typically, films were constructed on various substrates with approximate size of 1 × 2 in 2 . The substrate was first dipped into Dox-micelle solution (0.20 mg/mL, pH 7.4) for 10 min and rinsed three times with 10 mM phosphate buffer (pH 7.4) for 1 min each. Subsequently, the substrate was introduced into aqueous solution of tannic acid (0.50 mg/mL, 10 mM phosphate buffer, pH 7.4) for 10 min, washed again three times with 10 mM phosphate buffer (pH 7.4) for 1 min each. This cycle would provide one bilayer of Dox-micelle and tannic acid (TA) with a notation of (Dox-micelle/TA) 1 . The dipping process was repeated until desired number of bilayer was obtained.
F. LbL Film Characterizations.
Absorbance of the film was characterized with Varian Cary 600 UV/Vis spectrophotometer. Film thickness was measured with a surface profilometer (Tencor P16). Surface morphology of LbL film was observed by using Nanoscope IIIa AFM microscope (Digital Instruments, Santa Barbara, CA) in tapping mode in air.
G. pH-Induced Drug Release.
Drug release from the (Dox-micelle/TA) 40 film was followed by measuring the UV/Vis and fluorescence spectra of released drugs in a phosphate buffer under different pH conditions (pH 4 -7.4). The concentration of doxorubicin was calculated based on the calibration curves collected from UV/Vis absorbance (λ max = 480 nm) and fluorescence emission (λ ex = 479 nm, λ max = 593 nm, scan 500 -750 nm). After exposure to phosphate buffers for a predetermined time, each sample was gently dried with nitrogen and measured the thickness of film left on the substrate.
H. In vitro assay with HeLa cells.
HeLa cells were cultured as monolayers in RPMI 1640 medium supplemented with 10% fetal bovine serum and 50 units/mL penicillin and streptomycin inside an incubator maintained at 37 °C in a humidified environment (95% air/ 5% CO 2 ). Cells from flasks were trypsinized, counted and plated as necessary onto 96 (10K cells/well) or 6 (250K cells/well) well plates. Before each experiment, the well plates were checked for a similar level of cell confluence (ca. 70%). Drug eluents from the prepared films were released inside 500 µL of PBS. For MTT assay, 100 µL of each of the treatment solution was pipetted into each well plate (×4 per treatment) for incubation times of 24 h and 48 h. Post incubation, the incubation media was replaced with fresh media and 20 µL of MTT (5 mg/mL). After another 4 h incubation period, the cells were lysed with a solution of DMSO and 20% SDS (1:1 concentration). Cell viability was measured by detecting levels of formazan crystals formed by the MTT assay at an absorbance of 570 nm. All data reported are relative to non-treatment controls. Bright field microscope images were taken with a Zeiss Axiovert 200. A calcein cell viability assay (Invitrogen, used according to manufacturer's instructions) was used to visualize the number of live cells for fluorescence microscopy. 
